GR3006408T3 - - Google Patents
Info
- Publication number
- GR3006408T3 GR3006408T3 GR920402772T GR920402772T GR3006408T3 GR 3006408 T3 GR3006408 T3 GR 3006408T3 GR 920402772 T GR920402772 T GR 920402772T GR 920402772 T GR920402772 T GR 920402772T GR 3006408 T3 GR3006408 T3 GR 3006408T3
- Authority
- GR
- Greece
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Mycology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94189486A | 1986-12-15 | 1986-12-15 | |
| US94147386A | 1986-12-15 | 1986-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3006408T3 true GR3006408T3 (cg-RX-API-DMAC7.html) | 1993-06-21 |
Family
ID=27130157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR920402772T GR3006408T3 (cg-RX-API-DMAC7.html) | 1986-12-15 | 1992-12-02 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0274873B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPS63258585A (cg-RX-API-DMAC7.html) |
| KR (1) | KR880007553A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1023758C (cg-RX-API-DMAC7.html) |
| AU (1) | AU604806B2 (cg-RX-API-DMAC7.html) |
| DE (1) | DE3781878T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK654987A (cg-RX-API-DMAC7.html) |
| ES (1) | ES2052584T3 (cg-RX-API-DMAC7.html) |
| GR (1) | GR3006408T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HU199559B (cg-RX-API-DMAC7.html) |
| IE (1) | IE60394B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL84819A (cg-RX-API-DMAC7.html) |
| MX (1) | MX170925B (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ222895A (cg-RX-API-DMAC7.html) |
| PT (1) | PT86364B (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA879415B (en) * | 1986-12-15 | 1989-08-30 | Lilly Co Eli | Antibiotic a10255 complex and factors,microorganisms,process and production therefor |
| US5229362A (en) * | 1986-12-15 | 1993-07-20 | Eli Lilly And Company | Antibiotic A10255 complex and factors, and process and production therefor |
| ATE110784T1 (de) * | 1987-06-19 | 1994-09-15 | Sandoz Ag | Zyklische peptolide. |
| IT1234197B (it) * | 1988-06-14 | 1992-05-06 | Mini Ricerca Scient Tecnolog | Antibiotici ottenuti mediante coltivazione aerobica controllata dello streptomyces s.p. ncib 12629 |
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| KR20070120617A (ko) | 2001-01-26 | 2007-12-24 | 쉐링 코포레이션 | 치환된 아제티딘온 화합물을 포함하는 약제학적 조성물 |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| IL156445A0 (en) | 2001-01-26 | 2004-01-04 | Schering Corp | Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| EP1429756B1 (en) | 2001-09-21 | 2006-11-22 | Schering Corporation | Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| CA2504916A1 (en) | 2002-11-06 | 2004-05-27 | Schering Corporation | Cholesterol absorptions inhibitors for the treatment of autoimmune disorders |
| US20070164132A1 (en) | 2003-02-18 | 2007-07-19 | Keith Laidler | Spray nozzle |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| DE602004018617D1 (de) | 2003-03-07 | 2009-02-05 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
| WO2004081002A1 (en) | 2003-03-07 | 2004-09-23 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| WO2004081004A1 (en) | 2003-03-07 | 2004-09-23 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| EP2473516A1 (en) * | 2009-09-02 | 2012-07-11 | Piramal Life Sciences Limited | Antibiotic compounds |
-
1987
- 1987-12-14 IL IL84819A patent/IL84819A/xx not_active IP Right Cessation
- 1987-12-14 EP EP87310953A patent/EP0274873B1/en not_active Expired - Lifetime
- 1987-12-14 ES ES87310953T patent/ES2052584T3/es not_active Expired - Lifetime
- 1987-12-14 HU HU875637A patent/HU199559B/hu not_active IP Right Cessation
- 1987-12-14 NZ NZ222895A patent/NZ222895A/xx unknown
- 1987-12-14 DE DE8787310953T patent/DE3781878T2/de not_active Expired - Fee Related
- 1987-12-14 DK DK654987A patent/DK654987A/da not_active Application Discontinuation
- 1987-12-14 IE IE339087A patent/IE60394B1/en not_active IP Right Cessation
- 1987-12-14 AU AU82493/87A patent/AU604806B2/en not_active Ceased
- 1987-12-15 PT PT86364A patent/PT86364B/pt not_active IP Right Cessation
- 1987-12-15 JP JP62320067A patent/JPS63258585A/ja active Pending
- 1987-12-15 MX MX009771A patent/MX170925B/es unknown
- 1987-12-15 CN CN87108341A patent/CN1023758C/zh not_active Expired - Fee Related
- 1987-12-15 KR KR870014349A patent/KR880007553A/ko not_active Ceased
-
1992
- 1992-12-02 GR GR920402772T patent/GR3006408T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT86364B (pt) | 1990-11-07 |
| JPS63258585A (ja) | 1988-10-26 |
| AU8249387A (en) | 1988-07-28 |
| NZ222895A (en) | 1992-08-26 |
| HUT49376A (en) | 1989-09-28 |
| IL84819A (en) | 1993-07-08 |
| IE873390L (en) | 1988-06-15 |
| PT86364A (en) | 1988-01-01 |
| HU199559B (en) | 1990-02-28 |
| MX170925B (es) | 1993-09-22 |
| DK654987A (da) | 1988-09-23 |
| DE3781878T2 (de) | 1993-03-11 |
| ES2052584T3 (es) | 1994-07-16 |
| EP0274873A2 (en) | 1988-07-20 |
| KR880007553A (ko) | 1988-08-27 |
| EP0274873B1 (en) | 1992-09-23 |
| AU604806B2 (en) | 1991-01-03 |
| EP0274873A3 (en) | 1989-08-09 |
| DE3781878D1 (de) | 1992-10-29 |
| CN87108341A (zh) | 1988-08-10 |
| IE60394B1 (en) | 1994-07-13 |
| CN1023758C (zh) | 1994-02-16 |
| DK654987D0 (da) | 1987-12-14 |